Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,733 | -18,109 | -14,871 | -8,671 | -3,826 |
| Depreciation Amortization | N/A | 402 | 402 | 47 | 17 |
| Accounts payable and accrued liabilities | 937 | -41 | 1,072 | 1,143 | 63 |
| Other Working Capital | 726 | -663 | -56 | 804 | -352 |
| Other Operating Activity | -523 | 2,816 | 1,142 | -188 | 349 |
| Operating Cash Flow | $-3,593 | $-15,595 | $-12,311 | $-6,865 | $-3,749 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 32,429 | 31,967 | 31,967 | N/A |
| Other Financing Activity | 0 | -140 | -140 | -23 | 0 |
| Financing Cash Flow | $0 | $32,289 | $31,827 | $31,944 | $N/A |
| Beginning Cash Position | 30,344 | 13,650 | 13,650 | 13,650 | 13,650 |
| End Cash Position | 26,751 | 30,344 | 33,166 | 38,729 | 9,901 |
| Net Cash Flow | $-3,593 | $16,694 | $19,516 | $25,079 | $-3,749 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,593 | -15,595 | -12,311 | -6,865 | -3,749 |
| Free Cash Flow | -3,593 | -15,595 | -12,311 | -6,865 | -3,749 |